Results 311 to 320 of about 883,596 (386)

Safety of prostaglandins in the peripartum period in case of sickle‐cell disease: A multicenter cohort study

Pregnancy, Volume 1, Issue 5, September 2025.
Abstract Introduction Pregnancies with sickle‐cell disease are at high risk of maternal, obstetrical, and fetal complications, for which prostaglandins are often indicated to induce labor or to treat postpartum hemorrhage. There is concern that prostaglandin use may increase the risk of vaso‐occlusion, but to date no clinical study has yet assessed ...
Mayi Gnofam, Jeanne Sibiude, Louis Affo, Frédéric Galacteros, Edouard Lecarpentier, Florence Wang, Marine Driessen, Olivier Graesslin, Gylna Loko, Giovanna Cannas, Stéphane Bounan, Hervé Fernandez, Véronique Debarge, Caroline Makowski, Laurent Mandelbrot, for the Drepagest Study Group   +15 more
wiley   +1 more source

Arterial Embolization with n-Butyl-Cyanoacrylate for a Large Gluteal Intramuscular Hemangioma: A Case Report. [PDF]

Reports (MDPI)
Papalexis N, Carta M, Peta G, Quarchioni S, Di Carlo M, Miceli M, Facchini G.   +6 more
europepmc   +1 more source

Non‐Palpable Contraceptive Implant Evaluation and Removal: A Protocol That Can Be Adopted for Practice in Low‐Middle Income Countries

Public Health Challenges, Volume 4, Issue 3, September 2025.
This protocol provides a comprehensive stepwise approach for localization and removal of non‐palpable contraceptive implants that can be adopted for practice in low‐middle income countries such as Africa. In general, most non‐palpable contraceptive implants can be localized with ultrasound. Hence, no attempt should be made for a blind remove.
Abraham Fessehaye Sium, Amani Nureddin Abdu, Jaclyn M. Grentzer, Matthew F. Reeves, Sarah Prager   +4 more
wiley   +1 more source

Transcatheter arterial embolization in postpartum HELLP syndrome: A case report. [PDF]

Int J Surg Case Rep
Zhou X, Shi Q, Xie Z, Wang L, Gao L, Dai J.   +5 more
europepmc   +1 more source

Sequential Preoperative Arterial and Portal Venous Embolizations in Patients With Hepatocellular Carcinoma

, 2004
Taku Aoki
openalex   +1 more source

Review Article: Liver Transplantation for Hepatocellular Carcinoma in the Era of Immune Checkpoint Inhibitors

Alimentary Pharmacology &Therapeutics, Volume 62, Issue 6, Page 585-601, September 2025.
ICI is now the first‐line therapy for unresectable HCC and has revolutionised the management of advanced HCC and is now emerging as a modality for downstaging or bridging. The ideal timing of transplant after ICI should be at least 52 days. ABSTRACT Background Ablation, surgical resection and liver transplantation (LT) are curative therapies for ...
Anand V. Kulkarni, Amit G. Singal, K. Rajender Reddy   +2 more
wiley   +1 more source

Spontaneous hemorrhage in adrenal myelolipoma treated with elective laparoscopic adrenalectomy following selective arterial embolization. [PDF]

IJU Case Rep
Ito I, Takehara K, Miyazaki Y, Tsuchiyama A, Mukae Y, Hayakawa K, Sakamoto I, Irie J, Watanabe J.   +8 more
europepmc   +1 more source

Magnetic resonance imaging‐guided transurethral ultrasound ablation for benign prostatic obstruction: 1‐year clinical outcomes of a phase II study

BJU International, Volume 136, Issue 3, Page 473-483, September 2025.
Objectives To evaluate the safety and efficacy of magnetic resonance imaging (MRI)‐guided transurethral ultrasound ablation (TULSA) as a minimally invasive alternative for benign prostatic obstruction (BPO). Patients and Methods This prospective, single‐centre, early phase II study (NCT03350529) included 30 men with BPO scheduled for primary ...
Antti Viitala, Mikael Anttinen, Pietari Mäkelä, Heikki Pärssinen, Pertti Nurminen, Teija Sainio, Jani Saunavaara, Pekka Taimen, Roberto Blanco Sequeiros, Peter J. Boström   +9 more
wiley   +1 more source

Case Report: Durable remission after abscopal effect following transcatheter hepatic arterial embolization in a patient with mucosal melanoma refractory to immunotherapy. [PDF]

Front Immunol
Claus LM, Kostan HE, Hicks ME, Avritscher R, Davies MA.   +4 more
europepmc   +1 more source